MENU
+Compare
CGEM
Stock ticker: NASDAQ
AS OF
Apr 17 closing price
Price
$7.89
Change
+$0.28 (+3.68%)
Capitalization
461.67M

CGEM Cullinan Therapeutics Forecast, Technical & Fundamental Analysis

Cullinan Therapeutics Inc is a biopharmaceutical company... Show more

CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CGEM with price predictions
Apr 16, 2025

CGEM's RSI Indicator recovers from oversold territory

The RSI Oscillator for CGEM moved out of oversold territory on April 08, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 24 similar instances when the indicator left oversold territory. In of the 24 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CGEM just turned positive on April 11, 2025. Looking at past instances where CGEM's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CGEM advanced for three days, in of 225 cases, the price rose further within the following month. The odds of a continued upward trend are .

CGEM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 50 cases where CGEM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on April 16, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CGEM as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CGEM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CGEM entered a downward trend on April 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.782) is normal, around the industry mean (13.662). P/E Ratio (0.000) is within average values for comparable stocks, (62.714). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.754). Dividend Yield (0.000) settles around the average of (0.026) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (248.452).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CGEM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CGEM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CGEM is expected to report earnings to rise 11.74% to -81 cents per share on May 20

Cullinan Therapeutics CGEM Stock Earnings Reports
Q1'25
Est.
$-0.82
Q4'24
Beat
by $0.06
Q3'24
Beat
by $0.10
Q2'24
Missed
by $0.02
Q1'24
Beat
by $0.13
The last earnings report on March 03 showed earnings per share of -73 cents, beating the estimate of -79 cents. With 694.95K shares outstanding, the current market capitalization sits at 461.67M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
One Main Street
Phone
+1 617 410-4650
Employees
85
Web
https://www.cullinanoncology.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
BTC.X84895.750000861.882800
+1.03%
Bitcoin cryptocurrency
SPY526.410.75
+0.14%
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla

CGEM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEM has been loosely correlated with IDYA. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEM
1D Price
Change %
CGEM100%
+3.68%
IDYA - CGEM
39%
Loosely correlated
+5.56%
DNLI - CGEM
39%
Loosely correlated
+1.51%
ABOS - CGEM
39%
Loosely correlated
-8.08%
BDTX - CGEM
38%
Loosely correlated
+5.88%
BEAM - CGEM
38%
Loosely correlated
+2.29%
More